SKP.L Regulatory News (SKP)

9 Mar 2007 09:21

Skyepharma PLC09 March 2007 For Immediate Release 9th MARCH 2007 SkyePharma PLC SKYEPHARMA TO PRESENT AT COWEN & CO. 27th ANNUAL HEALTHCARE CONFERENCE LONDON, UK, 9 March 2007-- SkyePharma PLC (Nasdaq: SKYE; LSE: SKP) announcestoday that the Company's Chief Operating Officer, Dr Ken Cunningham, will make apresentation at the Cowen & Co. 27th Annual Healthcare Conference in Boston,USA. Dr Cunningham will deliver his presentation on Tuesday 13 March 2007 at4.45 p.m. (ET). For further information please contact: SkyePharma PLC +44 207 491 1777 Frank Condella, Chief Executive OfficerKen Cunningham, Chief Operating OfficerPeter Grant, Finance Director Buchanan Communications +44 207 466 5000 Tim Anderson / Mark Court / Rebecca Skye Dietrich The Trout Group + 1 617 583 1308 Seth Lewis About SkyePharma PLC Using its proprietary drug delivery technologies, SkyePharma develops newformulations of known molecules to provide a clinical advantage and life-cycleextension. The Company has nine approved products in the areas of oral,inhalation and topical delivery that are marketed throughout the world byleading pharmaceutical companies. For more information, visit www.skyepharma.com. This information is provided by RNS The company news service from the London Stock Exchange